Literature DB >> 26806149

Diabetic foot infection in hospitalized adults.

David E Katz1, N Deborah Friedman2, Evgenia Ostrovski3, Dor Ravid4, Nadav Amrami4, Dori Avivi4, Bethlehem Mengesha4, Ronit Zaidenstein5, Tsilia Lazarovitch6, Mor Dadon4, Dror Marchaim7.   

Abstract

BACKGROUND: Acute infections of the diabetic foot (DFI) are a common and complex condition. Patients are generally managed in the ambulatory setting and epidemiological data pertaining to hospitalized patients is lacking. The aim of this study was to analyze the epidemiology, microbiology and outcomes of hospitalized patients with DFI, who are managed at a referral center equipped with hyperbaric oxygen (HBO) therapy.
METHODS: A retrospective cohort study of adult patients admitted to a tertiary referral center with DFI over a six-month period in 2013 was undertaken. Predictors of clinical outcomes and efficacy of treatment modalities were analyzed by Cox regression.
RESULTS: Sixty-one patients with DFI were identified. Most patients were elderly (67 ± 13 years), with long-standing (17 ± 9 years), poorly controlled (HbA1c 9 ± 3%) diabetes. Most patients had polymicrobial infection (80%); specifically, anaerobic (39%) and multi or extensively-drug resistant organisms (61%). Administration of appropriate antimicrobials was delayed for >48 h in 83%. Advanced age was associated with worse outcomes. Sicker patients with severe peripheral vascular disease were managed with HBO. The use of HBO was associated with higher costs and increased functional deterioration, and did not prevent future limb amputation.
CONCLUSIONS: Our study illustrates the descriptive epidemiology of hospitalized adults with DFI predominantly of polymicrobial etiology. MDROs and anaerobic organisms are common causative pathogens, and appropriate antibiotics were frequently delayed. HBO treatment may delay the need for limb amputation, but not obviate this eventual outcome.
Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; DFI; Diabetes; Hyperbaric oxygen; SSTI; Skin and soft tissue infections

Mesh:

Substances:

Year:  2016        PMID: 26806149     DOI: 10.1016/j.jiac.2015.12.007

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  7 in total

1.  Antimicrobial Susceptibility Testing and Phenotypic Detection of MRSA Isolated from Diabetic Foot Infection.

Authors:  Khanda Anwar; Dlsoz Hussein; Jamal Salih
Journal:  Int J Gen Med       Date:  2020-12-02

2.  Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon.

Authors:  Lamia Jouhar; Rola F Jaafar; Rakan Nasreddine; Omar Itani; Fady Haddad; Nisrine Rizk; Jamal J Hoballah
Journal:  Int Wound J       Date:  2020-08-11       Impact factor: 3.315

Review 3.  Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis.

Authors:  Catherine Dunyach-Remy; Christelle Ngba Essebe; Albert Sotto; Jean-Philippe Lavigne
Journal:  Toxins (Basel)       Date:  2016-07-07       Impact factor: 4.546

4.  Bacterial distribution, changes of drug susceptibility and clinical characteristics in patients with diabetic foot infection.

Authors:  Ling Liu; Zhihui Li; Xinxin Liu; Shan Guo; Limin Guo; Xuelian Liu
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

5.  Association of Proteus mirabilis and Providencia stuartii Infections with Diabetes.

Authors:  Maria Rus; Monica Licker; Corina Musuroi; Delia Muntean; Silvana Vulpie; Oana Magiar; Teodora Sorescu; Silvia Ioana Musuroi; Adela Voinescu; Luminita Mirela Baditoiu
Journal:  Medicina (Kaunas)       Date:  2022-02-11       Impact factor: 2.430

6.  Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection.

Authors:  Xi Yan; Jin-Fang Song; Liang Zhang; Xia Li
Journal:  BMC Endocr Disord       Date:  2022-02-21       Impact factor: 2.763

7.  Predictors of intra-hospital mortality in patients with diabetic foot ulcers in Nigeria: data from the MEDFUN study.

Authors:  Olufunmilayo O Adeleye; Ejiofor T Ugwu; Ibrahim D Gezawa; Innocent Okpe; Ignatius Ezeani; Marcelina Enamino
Journal:  BMC Endocr Disord       Date:  2020-08-28       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.